WeightWatchers Prepares for Bankruptcy as Weight Loss Drug Demand Surges

WW International faces overwhelming debt and declining relevance in a market transformed by GLP-1 weight loss drugs.

WW International, formerly WeightWatchers, is reportedly planning to file for bankruptcy in the coming months due to financial struggles and market shifts.
The company has over £135 million in debt due next year and more than £1 billion in loans and bonds maturing in 2028 and 2029.
The rise of GLP-1 weight loss drugs like Ozempic, Wegovy, and Mounjaro has disrupted the traditional weight management industry, reducing demand for WW's programs.
WW's stock has plummeted, trading at just $0.18 after a 62% drop in a single day, reflecting a collapse in investor confidence.
The departure of Oprah Winfrey from the company’s board in 2024 further weakened investor trust, as she shifted focus to advocating for weight loss medications.